Giant Biogene Holding Co. Ltd. ( (HK:2367) ) just unveiled an announcement.
Giant Biogene Holding Co., Ltd has announced a board meeting scheduled for March 26, 2025, to discuss and approve the final results for the year ending December 31, 2024, and to consider a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd is a company incorporated in the Cayman Islands, operating in the biotechnology sector. The company focuses on developing and providing biogene-related products and services, with a market presence in the People’s Republic of China.
YTD Price Performance: 45.89%
Average Trading Volume: 3,010,235
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$74.03B
Find detailed analytics on 2367 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com